ค้นหาแพทย์

นพ.วิชัย เส้นทอง

อายุรแพทย์โรคหัวใจ This email address is being protected from spambots. You need JavaScript enabled to view it. 043-232700 ศูนย์หัวใจสิริกิติ์ ภาคตะวันออกเฉียงเหนือ

Vichai Senthong


POSITION 
: Lecturer

Office Address : Cardiovascular Unit, Department of Internal Medicine,
                             Faculty of Medicine, Khon Kaen University, Khon Kaen 40002,                                       Thailand

Phone: 66-43-363-664, 66-81-545-3595
E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.
      

DOCTOR SCHEDULE

Doctor Schedule/ตารางแพทย์ออกตรวจ
  ห้องตรวจ:  อายุรกรรมผู้ป่วยนอก
  วันออกตรวจ:  อังคาร
  คลินิกนอกเวลา:  เสาร์
  พรีเมี่ยมคลนิก:  -

EDUCATION :

    2003     Doctor of Medicine (M.D.) Faculty of Medicine, Khon Kaen University.
    2007     Thai Board Certified in Internal Medicine.
    2009    Thai Board Certified in Cardiology.
    

HONOURS/AWARDS:

     2008    First prize in Thai Heart Association Award for Thai cardiology fellowship research proposal.
     

WORKING EXPERIENCES:

     2003-2007  Internal Medicine Resident, Faculty of Internal Medicine, Khon Kaen University, Khon Kaen, Thailand
     2007-2009  Cardiology Fellow, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
     2009- present  Lecturer, Cardiovascular Unit Department of Internal Medicine, Faculty of Medicine Khon Kaen University

CLINICAL SKILL EXPERIENCES:

Research Grant Support:

     2007-present: Effects of metoprolol tartrate versus carvedilol on clinical outcomes and central aortic pressure in patients with chronic heart failure (PI).
     2008-present: The SEPIA-PCI Trial: Otamixaban in Comparison to Heparin in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention (Co-PI).
     2009-present: A Comparison of Prasugrel and Clopidogrel in Acute Coronary SyndromeSubjects (TRILOGY ACS) (Co-PI).
     2009-present: ALECARDIO Cardiovascular outcomes study to evaluate the potential of aleglitazar to reduce cardiovascular risk in patients with a recent acute coronary syndrome (ACS) event and type 2 diabetes mellitus (T2D)(PI).
     2010-present: A 24-MONTH, MULTI-CENTER, OPEN-LABEL, RANDOMIZED, CONTROLLED TRIAL TO INVESTIGATE EFFICACY, SAFETY AND EVOLUTION OF CARDIOVAS CULAR PARAMETERS IN DE NOVO RENAL TRANSPLANT RECIPIENTS AFTER EARLY CALCINEURIN INHIBITOR TO EVEROLIMUS CONVERSION (Co-PI).

PRIVILEGE :

  • Coronary Angiogram
  • Percutaneous Coronary Intervention
  • Rotablator
  • IVUS
  • FFR
  • OCT
  • Temporary Pacemaker
  • Intra Aortic Ballon pump
  • Peripheral Angiogram (AVF/AVG)
  • Peripheral Angiogram (Carotid artery)
  • Pericardial tapping
  • Fluoroscopy
  • trans thoracic echo
  • trans esophageal echo
  • Exercise stress test
  • Holter monitoring
  • Tilt table test
Rate this article 1 Vote

About The Author

SU

This email address is being protected from spambots. You need JavaScript enabled to view it.